Thermo Fisher Scientific Inc. (TMO) TD Cowen 45th Annual Health Care Conference - (Transcript)

Group 1 - The life science industry showed modest improvement throughout 2024, with expectations for ongoing progress in 2025 [4] - Thermo Fisher Scientific posted strong fourth quarter earnings and provided positive financial guidance for 2025 [4] - The company indicated that 2023 was a challenging year for the industry, but they anticipated sequential market improvement in 2024 [5] Group 2 - The company expected the markets to be slightly down for the year but aimed to continue gaining market share [5] - The management highlighted the importance of understanding the evolving market backdrop and how it influenced their performance and strategy [5]